Regulatory Impact Analysis on Cannabis approved
Approved by Anvisa’s Dicol, the Regulatory Impact Analysis (RIA) report on cannabis products offers a comprehensive assessment of the regulatory scenario for medicinal cannabis in Brazil, suggesting improvements to the current regulations.
If you need more information on regulatory issues, ELS can certainly help.
ontact your local ELS consultant or via email info@elssolutions.pt
ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.
Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.
Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.
